Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: J Shoulder Elbow Surg. 2020 Aug 4;29(12):2459–2475. doi: 10.1016/j.jse.2020.07.030

Figure 2.

Figure 2

Change in CMS for each treatment strategy compared to MCID threshold for either nonoperative or operative intervention. Sample size is directly proportional to the size of the circle (or triangle for arthroscopic tendon transfer). Influenced by the sample size, the red “x” denotes the weighted average change in CMS for all treatment strategies except tendon transfer. The “T” denotes the weighted average change in CMS for all tendon transfers. The blue “a” represents the weighted average change in CMS for arthroscopic tendon transfer. The green “o” represents the weighted average change in CMS for open tendon transfer. PT, Physical therapy; D, Débridement; PR, Partial repair; GI, Graft interposition; TTA, Arthroscopic tendon transfer; TTO, Open tendon transfer; SCR-HDA, Superior capsular reconstruction—human dermal allograft; SCR-TFL, Superior capsular reconstruction—tensor fascia lata autograft; BA, Balloon arthroplasty; RSA, Reverse shoulder arthroplasty; MCID, Minimum clinically important difference.